Effect of a Ghrelin Receptor Agonist on Muscle and Bone

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 5, 2019

Primary Completion Date

January 26, 2023

Study Completion Date

January 26, 2023

Conditions

SarcopeniaOsteopenia

Interventions

DRUG

Anamorelin Hydrochloride

Ghrelin receptor agonist

DRUG

Placebo

placebo is a inert substance

Trial Locations (1)

Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston

All Listed Sponsors

collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Tufts University

OTHER

NCT04021706 - Effect of a Ghrelin Receptor Agonist on Muscle and Bone | Biotech Hunter | Biotech Hunter